Grace Therapeutics Investor Relations Material
Latest events
KOL Event
Grace Therapeutics
Q4 2025
23 Jun, 2025
Q3 2025
12 Feb, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Grace Therapeutics Inc
Access all reports
Acasti Pharma Inc is a biopharmaceutical company focused on developing and commercializing therapies for rare and orphan diseases. The company utilizes proprietary delivery platforms for small molecule drug candidates targeting neurological and cardiovascular conditions. The company is headquartered in Laval, Canada, and its shares are listed on the NASDAQ.
Latest articles
)
Citadel: Relentless Optimization at Global Scale
From a Harvard dorm to global dominance, this is the story of how Ken Griffin created one of the best-performing hedge funds of all time.
4 Jul 2025
)
David A. Ricks: Eli Lilly's Chairman and CEO
David Ricks built a decades-long career at Eli Lilly, now leading the giant company through a defining moment in its long pharmaceutical history.
3 Jul 2025
)
D. E. Shaw & Co: Inside the Quiet Giant of Quant Finance
A deep dive into D. E. Shaw's evolution from a $28M quant startup to a $65B hedge fund giant, built on research, computing, and quiet consistency.
2 Jul 2025
Ticker symbol
GRCE
Country
🇺🇸 United States